Optibiotix Health Share Discussion Threads

[onedayrodders] 07/11/2017 13:35

Chris ...start your messages with "Only me"

[chrisg11] 07/11/2017 13:33

Hello

Its me again..

Every couple of posts or so it seems someone states that the LPLDL trial has been peer reviewed and I am absolutely sure it has but where can I find these peer reviews?

I am sure elrico has one so can someone ask him to post it on here instead of keep repeating the same things on here ad nauseum.

I am trying to do some honest research so please link me to at least one peer review so I can read their comments.

Thank you to anyone who hasn't filtered me due to my quest for evidence.

[slartybartfaster] 07/11/2017 13:16

Be careful there elrico it be construed you are being negative and we cant have that. lol

[rafboy] 07/11/2017 11:06

m4rtinu, fair enough bur hopefully the PR push will help that along.

[m4rtinu] 07/11/2017 10:36

Elrico - thanks again.

Rafboy - I don't think the public are necessarily stupid, but sometimes they are not interested in detail; important though it might be.

Anyway, regarding SP: it seems to have settled in 70s quite comfortably. On a lighter note, I did wonder if the sells this am were people selling a few shares to buy their supplies of probiotics :)

[elrico] 07/11/2017 10:25

Martin - As I understand it, corporates are approaching OPTI because their products/IP has strong scientific backing. The BOD have wheels in motion to further validate this with larger human studies - see the new SACCO deal announced. There will also be a PR push to make the public aware of the science backing. The recent FDA approval is a key step in this direction. Also, the growing public awareness is also key. Christina and Max gave us an insight into how the company are thinking in terms of markets and public perception and how they will approach this and the market specific sectors.

[rafboy] 07/11/2017 10:15

How can it? Once the public is made aware of the science behind the products and I'm sure they will, then the public are not stupid. Would you buy something that the company says will work or would you buy it from the company that not only says it works but is backed by science and can be proven to be effective?

I think much will depend on the media campaign that goes alongside the product launch.

[m4rtinu] 07/11/2017 10:04

Thanks, I will find a more comfortable chair and read!

Just a follow up. I did express a worry before about possible competitors with lesser products/ research not done. In your words Elrico " ... plenty of competition, but much of it is NOT science backed or peer reviewed". Will this cloud the public's impressions? And might this adversely affect OPTI, who are playing by the rules of science. I hope not.

[elrico] 07/11/2017 09:47

Martin - It all depends on what you mean by competition. PLC the main players are pharma route companies like Seres Therapeutics and 4D Pharma - both are thought to be c4-5 years away from any kind of commercial products. In terms of probiotic markets, there is plenty of competition, but much of it is NOT science backed or peer reviewed whereas OPTI's IP is science backed and in LP-LDL's case, peer reviewed.

This link may help you understand a little better, though it is 2 years old and the market is growing faster than the stats show in this article. However, it is the companies withing the functional supplements market you may find more helpful.



Another risk factor is public take up of new products, there is a great deal of interest from multiple multinationals wanting access to OPTI's IP and products, so the main risk is not a concern, it's the public now and this will take time to get a real data on.

[asterix96] 07/11/2017 09:33

Everyone else is playing catch up!

[m4rtinu] 07/11/2017 09:14

Thanks for links guys/guyesses. I'm new to OPTI and still learning about it's products. I'm also not that strong on Biology!

Just a quick question: as there is so much interest in the microbiome and various benefits a healthy gut can give, what is the competition like in OPTI's field of interest?

Thanks in advance. MU

[rafboy] 07/11/2017 08:55

I was very impressed with their enthusiasm and drive. Also they are ensuring the science stacks up which I believe is very important. So Jan/Feb next year may see some big news.

[woodaldo] 07/11/2017 08:41

I'm hoping they introduce sweetbiotix with the slimbiome to the go-figure range. Nutrient rich, with no sugar (but sweet tasting) and added bonus of weight loss. Also I'd I've liked to hear more more Chistrina and Max about new distribution outlets. Boots anyone?

[parob] 07/11/2017 07:34

An understanding of the gut's importance to our wellbeing now fuels a global probiotic market projected to grow to $64bn (£48bn) by 2023.

[parob] 07/11/2017 07:26

In today's Guardian:



Is your gut microbiome the key to health and happiness?

[2350220] 06/11/2017 23:10

Thanks so much for posting the link Parob.
Stupidly, I watched it at 11pm . . .
Now I won't be able to sleep a wink because of thinking about the massive prospects ahead of us.
I thought that they both came across really really well.
Enthusiastic and on the top of their game, if that's the correct phrase.

Exciting times indeed, if Trump doesn't succeed in blowing us all up that is.
John

[judijudi] 06/11/2017 22:09

Great interview
On the cutting edge of the Microbiome Tsunami!!
:)

[elrico] 06/11/2017 21:28

Max gave us a big clue in the interview. Pops tarts

edited wrong link posted by senile old git ;)

[parob] 06/11/2017 20:00

A repost of this excellent interview released today for those that missed it earlier. Highly recommended viewing!

Massive opportunities for OptiBiotix Health's new and improved SlimBiome

Andrew Scott

Christina Wood, Sales & Marketing Director for OptiBiotix Health plc(LON:OPTI) and Max Tomlinson, founder and creator of GoFigure, update Proactive's Andrew Scott on the commercial progress being made with SlimBiome.

Slimbiome is their patented combination of natural ingredients which supports scientifically substantiated weight loss claims.

OptiBiotix has recently signed a profit sharing agreement with Knighton Foods, which will manufacture and distribute SlimBiome.

[riskybusiness1] 06/11/2017 19:28

NB - There must already be some sort of collaboration as Sacco will have to supply TATA as LPGOS is extracted directly from the LPLDL strain using Optis patented reverse enzyme technology. This technology is pretty much the key to create specific prebiotic fibres for specific strains to manipulate the microbiome. Opti are the worlds first Microbiome company to prove this concept with its LPLDL strain - presented by Prof Bob Rastall at SAN Diego last week. Imagine owning the IP for the intel processor that enhances your computer performance etc. Translate that to microbiome strains - Opti own the IP that makes it possible to create a targeted specific fibre from a strain that is the ultimate performance enhancer for that strain in terms of strain growth rate and the associated health benefits that this comes with. Try and put a value on that technology when the space really come alive.

[pglancy] 06/11/2017 19:27

Look who is trying to keep michaelmouse special thread alive. No toffee apple for the correct guess.

[nblg] 06/11/2017 17:34

risky, thanks for your post (28806). You state "The combination of LPLDL and LPGOS as an Optibiotic will clearly be the Optimised version of LPLDL", which was very much my thinking and why I raised the point. My thinking now is that sacco and tata could come to an agreement, with sacco supplying lpldl to tata, and tata supplying lpgos to sacco. It would be one way to get what could be the trump product onto the market. Such an arrangement, if properly made, could have a mutual benefit for both companies, not to mention opti.

[monkeywench1] 06/11/2017 15:29

Slarty I think we all guessed you are not a sophisticated investor.

[riskybusiness1] 06/11/2017 15:11

Back in to the buyers range....